Canada markets closed

Rohto Pharmaceutical Co.,Ltd. (RPHCF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
20.490.00 (0.00%)
At close: 04:36PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-03-31
2022-03-31
2021-03-31
Total Revenue
263,564,000
238,664,000
199,646,000
181,053,000
Cost of Revenue
110,158,000
101,243,000
83,476,000
74,326,000
Gross Profit
153,405,000
137,421,000
116,170,000
106,726,000
Operating Expenses
Research Development
-
11,065,000
8,740,000
7,903,000
Selling General and Administrative
-
46,467,000
38,114,000
40,525,000
Total Operating Expenses
112,776,000
103,457,000
87,151,000
83,732,000
Operating Income or Loss
40,629,000
33,964,000
29,019,000
22,994,000
Interest Expense
233,000
247,000
248,000
145,000
Income Before Tax
41,333,000
34,290,000
27,874,000
23,006,000
Income Tax Expense
10,207,000
7,860,000
6,686,000
6,236,000
Income from Continuing Operations
31,126,000
26,430,000
21,188,000
16,770,000
Net Income
30,897,000
26,377,000
21,127,000
16,743,000
Net Income available to common shareholders
30,897,000
26,377,000
21,127,000
16,743,000
Basic EPS
130.53
115.62
92.61
73.39
Diluted EPS
130.16
115.29
92.34
73.18
Basic Average Shares
228,139
228,139
228,140
228,140
Diluted Average Shares
228,788
228,788
228,796
228,792